Facilitated By

San Antonio Medical Foundation

News

  • Adding Everolimus to Adjuvant ET Does Not Improve Survival in High-Risk HR+/HER2

    ... to research presented at the San Antonio Breast Cancer Symposium 2022. ... Disclosure: Some study authors declared affiliations with biotech, ...

  • SABCS: Enhertu neoadjuvant trial has caveats, Daiichi exec says - Fierce Pharma

    ... M.D., said in an interview ahead of the 2022 San Antonio Breast Cancer ... Pfizer will work with the biotech to identify a PLpro candidate to ...

  • Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at the ... - Yahoo Finance

    ... a poster presentation at the 2022 San Antonio Breast Cancer Symposium. ... Alan H. Auerbach, CEO and President of Puma Biotechnology, added, ...

  • Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at the 2022 San ...

    Puma Biotechnology Presented Updated Findings from the TBCRC-022 Trial in a poster presentation at the 2022 San Antonio Breast Cancer Symposium.

  • San Antonio jury finds former Border Patrol agent guilty of capital murder. | TPR

    Sign up for it here. Updated 8:00pm. A jury in San Antonio found Juan David Ortiz guilty of the capital murder carrying a life sentence without the ...